Skip to Content

'
Eddie K. Abdalla, M. D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Office Address

The University of Texas M. D. Anderson Cancer Center
P.O. Box 301402
Houston, TX 77230-1402

Education & Training

Degree-Granting Education

1993 The University of Michigan College of Medicine, Ann Arbor, MI, MD, Doctor of Medicine
1989 The University of Michigan, Ann Arbor, MI, BS, Cellular and Molecular Biology

Postgraduate Training

2002-2003 Fellowship, Hepatobiliary Surgery, Hôpital Beaujon, Paris, France, Pr. Jacques Belghiti, M.D.
1999-2002 Fellowship, Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
1994-1999 Residency, General Surgery, University of Florida College of Medicine, Gainesville, FL
1993-1994 Internship, General Surgery, University of Florida College of Medicine, Gainesville, FL

Board Certifications

12/2008 American Board of Surgery (General Surgery)

Experience/Service

Academic Appointments

Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2003-2008

Administrative Appointments/Responsibilities

Faculty Liaison for the Advanced Care Practitioners, Department of Surgical Oncology, Division of Surgery, UTMD Anderson Cancer Center, Houston, TX, 1/2003-present

Other Appointments/Responsibilities

T-32 Post-Doctoral Fellow, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2000-2001
Post-Doctoral Fellow, University of Florida College of Medicine, Gainesville, FL, 1996-1997
Research Fellow, University of Michigan College of Medicine, Ann Arbor, MI, 1987-1989
Research Assistant, Cleveland Clinic Foundation, Cleveland, OH, 1987

Honors and Awards

2009 America's Top Surgeons Award, Consumers' Research Council of America
2007 Teacher of the Year Award, The University of Texas M.D. Anderson Cancer Center, Department of Surgical Oncology
2006 Recipient, The University of Texas M. D. Anderson Cancer Center for Biomedical Engineering Summer Internship Students Teacher Award
2001-2002 Clinical Excellence Award, The University of Texas M. D. Anderson Cancer Center
2000-2001 National Institutes of Health T-32 Research Fellow, The University of Texas M. D. Anderson Cancer Center
2000 Recipient, Molecular Biology in Clinical Oncology: A Workshop
1999-2001 Fellow Representative, The University of Texas M. D. Anderson Cancer Center

Selected Publications

Peer-Reviewed Original Research Articles
1. Hassan M, Kaseb A, Li D, Vauthey JN, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Abbruzzese JL. Association between hypothyroidism and hepatocellular carcinoma: USA case-control study. Hepatology, 5/2009.
2. Nathan H, Aloia, TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16(1):14-22, 2009.
3. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16(3):614-622, 2009.
4. Zalinski S, Palavecino M, Abdalla EK. Hepatic resection for gastrointestinal stromal tumor liver metastases. Hematol Oncol Clin N Am 23:115-127, 2009.
5. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 164:836-847, 2009.
6. Katz MHG, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PWT, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-847, 2009.
7. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JV, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese J, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3487-95, 7/2008.
8. Vauthey JN, Palavecino M, Curley SA, Abdalla EK. Re: Right hepatic trisectionectomy for hepatobiliary disease: results and an appraisal of its current role. Ann Surg 248(1):139-9, 7/2008.
9. Yao JC, Hassan M, Leary C, Mares J, Abdallla EK, Fleming J, Vauthey JN, Rashid A. One hundred years after "Carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 38,825 cases in the United States. Journal of Clinical Oncology 26(18):3063-3072, 6/2008.
10. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Boderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5):833-46, 5/2008.
11. Ribero D, Abdalla EK, Vauthey JN. Authors' reply: Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 95(3):398-9, 3/2008.
12. Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, Vauthey JN. Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg 12(1):123-8, 1/2008.
13. Thomas MB, Tetzlaff E, Lozano R. Samp L, Butler CE, Gannon C, Hamilton S, Vauthey JN, Abdalla EK. Curing hepatocellular carcinomatosis with biologic therapy and surgery: achieving the impossible. J Surg Oncol 97(1):82-4, 1/2008.
14. Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, Ribero D, Zorzi D, Vauthey JN, Torzilli G. Treatment of Large and Advanced Hepatocellular Carcinoma. Ann Surg Oncol 15(4):997-85, 1/2008.
15. Overman MJ, Fogelman D, Al-Kali A, Crane CH, Evans D, Abdalla EK, Pisters P, Kopetz S, Eng C, Wolff RA. Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases. Clin Colorectal Cancer 7(5):338-42, 2008.
16. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol 15(10):2765-72, 2008.
17. Hassan MM, Spitz MR, Thomas MB, El-Deeb AS, Glover KY, Nguyen NT, Chan W, Kaseb A, Curley SA, Vauthey JN, Ellis LM, Abdalla EK. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Intl J Cancer 123(8):1883-91, 2008.
18. Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley SA, Pisters PW, Evans DB, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 15(11):3147-56, 2008.
19. Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Vauthey JN. Is embolization of segment 4 portal veins prior to extended right hepatectomy justified? Surgery 144(5):744-51, 2008.
20. Blazer DG, Kishi Y, Maru M, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26(33):5344-51, 2008.
21. Kesmodel SB, Ellis LM, Change GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 26(32):5254-60, 2008.
22. Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JN. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110(12):2761-7, 12/2007.
23. Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14(12):3481-91, 12/2007.
24. Ribero D, Donadon M, Madoff DC, Loyer EM, C, Abdalla EK, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386-94, 11/2007.
25. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JC, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases: Perioperative Safety and Survival. J Gastrointest Surg 11(11):1498-504, 11/2007.
26. Abdalla EK, Vauthey JN. Steatosis as a risk factor in liver surgery. Ann Surg 246(2):340-1, 8/2007.
27. Donadon M, Abdalla EK, Vauthey JN. Liver hanging maneuver for large or recurrent right upper quadrant tumors. J Am Coll Surg 204:329-33, 2/2007. PMID: 17254939.
28. Zorzi D, Vauthey JN, Lauwers GY, Laurent A, Abdalla EK. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful? Br J Surg 94:274-86, 2007.
29. Kodama Y, NG CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of CT methods for determining fat content of the liver. Amer J Roentgenology 188:1307-12, 2007.
30. Aloia TA, Pisters PWT, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary G, Crane CH, Evans DB. Delayed recovery after pancreaticoduodenectomy: A major factor impairing the delivery of adjuvant theapy? J Am Coll Surg 204:347-55, 2007.
31. Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN. Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007 204:854-62; discussion 862-4, 2007.
32. Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, Curley SA. High resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Amer J Surg 193:702-6, 2007.
33. Raut C, Tseng J, Sun C, Cleary K, Wang H, Wolff R, Abbruzzese J, Varadhachary G, Tamm E, Crane C, Gomez H, Hwang R, Vauthey JN, Abdalla EK, Lee J, Pister PWT, Evans D. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg Onc 246(1):52-60, 2007.
34. Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN. New paradigm in the management of liver only metastases from colorectal cancer. Gastrointest Ca Res 1:20-27, 2007.
35. Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P. Outcome of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 204(5):1016-1027, 2007.
36. Choi EA, Abdalla EK. Patient selection and outcome of hepatectomy for noncolorectal liver metastases. Surg Oncol Clin NA 16(3):557-77, 2007.
37. Abdalla EK, Ribero D, Pawkik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11:66-72, 2007.
38. Van Buren III G, Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Somcio R, Fan F, Camp ER, Yao JC, Ellis LM. The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res 13(16):4704-12, 2007.
39. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1271-80, 10/2006. PMID: 16955381.
40. Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK. Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 12:6556-8, 10/2006. PMID: 17072991.
41. Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 141:537-43; discussion 543-4, 6/2006. PMID: 16785353.
42. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-72, 5/2006. PMID: 16648507.
43. Abdalla EK, Vauthey JN. Colorectal metastases: resect or ablate? Ann Surg Oncol. 24:2679, 5/2006.
44. Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, Aloia TA, Curley SA, Camacho LH, Capussotti L, Elias D, Vauthey JN. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 13:712-20, 5/2006. PMID: 16538410.
45. Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460-6; discussion 466-7, 5/2006. PMID: 16702517.
46. Ribero D, Abdalla EK, Thomas MB, Vauthey JN. Liver resection in the treatment of hepatocellular carcinoma. Expert Rev Anticancer Ther 6:567-79, 4/2006. PMID: 16613544.
47. Abdalla EK, Eng C, Madary A, Vauthey JN. Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clin Colorectal Cancer 5:436-9, 3/2006. PMID: 16635283.
48. Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 10:240-8, 2/2006. PMID: 16455457.
49. Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, Curley SA, Mentha G, Capussotti L, Vauthey JN. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10:86-94, 1/2006. PMID: 16368496.
50. Abdalla EK. Is anatomic resection superior to nonanatomic resection for the treatment of patients with hepatocellular carcinoma? Nat Clin Pract Gastroenterol Hepatol 3:18-9, 1/2006. PMID: 16397606.
51. Abdalla EK, Vauthey JN. Improved survival after resection of colorectal liver metastases. J Clin Oncol 24:2479, 2006.
52. Ribero D, Abdalla EK, Thomas MB, Vauthey JN. Liver resection in the treatment of Hepatocellular carcinoma. Expert Rev Anticancer Ther 6:567-79, 2006.
53. Madoff DC, Abdalla EK, Wallace MJ, Ng CS, Ribero D, Vauthey JN. Portal vein embolization: a preoperative approach to improve the safety of major hepatic resection. Curr Med Imaging Rev 2:385-404, 2006.
54. Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 10:86-94, 2006.
55. Madoff DC, Abdalla EK, Wallace MJ, Murthy R, Ahrar K, Gupta S, Wei SH, Hicks ME, Vauthey JN. Sequential transcatheter arterial chemoembolization and portal vein embolization before major hepatectomy for patients with hepatocellular carcinoma. Cardiovasc Interv Radiol:202, 2006.
56. Zorzi D, Abdalla EK, Pawlik TM, Brown TD, Vauthey JN. Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13:347-50, 2006. PMID: 16858548.
57. Pawlik TM, Abdalla EK, Thomas M, Roh MS, Lauwers GY, Ribero D, Poon RT, Belghiti J, Nagorney DM, Vauthey JN. Staging of hepatocellular carcinoma. Hepatology 42:738-40, 9/2005.
58. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Tranpl 11/9:1086-92, 9/2005.
59. Abdalla, EK, Aloia TA, Vauthey JN. Laparoscopy for diagnosis and staging of hepatobiliary malignancies. Surg Prac.78-89, 8/2005.
60. Aloia TA, Zorzi D, Abdalla EK, Vauthey JN. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 242:172-7, 8/2005. PMID: 16041206.
61. Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140:584-9; discussion 589-91, 6/2005. PMID: 15967906.
62. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: Evolution of a new standard of care. J Vasc Interv Radiol 16:779-90, 6/2005. PMID: 15947041.
63. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450-7; discussion 457-8, 5/2005. PMID: 15897440.
64. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-22, discussion 722-4, 5/2005. PMID: 15849507.
65. Van Deusen MA, Abdalla EK, Vauthey JN, Roh MS. Staging classifications for hepatocellular carcinoma. Expert Rev Mol Diagn 5:377-83, 5/2005. PMID: 15934814.
66. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, Kianmanesh R, Ng IO, Curley SA, Yamaoka Y, Lauwers GY, Vauthey JN. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study. Surgery 137:403-10, 4/2005. PMID: 15800485.
67. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: Improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16:215-25, 2/2005. PMID: 15713922.
68. Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB (Oxford) 7(4):254-8, 2005.
69. Mullen JT, Lee JH, Gomez, HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee,JE, Pisters PWT, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9:1104-05, 2005.

Last updated: 9/21/2009